Proton NMR spectroscopy is emerging from translational and preclinical neuroscience
research as an important tool for evidence based diagnosis and therapy monitoring. It …

Imaging devices for small animals have emerged in the past 10 years as extraordinarily
useful tools in translational research and drug development. The Food and Drug …

We present a completely revised generation of a modular micro-NMR detector, featuring an
active sample volume of∼ 100 nL, and an improvement of 87% in probe efficiency. The …

Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment.
Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but …

Glioblastomas (GBs) are malignant brain tumours with poor prognosis even after aggressive
therapy. Programmed cell death-1 (PD-1) immune checkpoint blockade is a promising …

Simple Summary Glioblastoma (GB) is a malignant brain tumour with no cure, even after the
best treatment. The evaluation of a therapy response is usually based on magnetic …

Glioblastomas (GB) are brain tumours with poor prognosis even after aggressive therapy.
Improvements in both therapeutic and follow‐up strategies are urgently needed. In previous …

Glioblastoma (GBM) causes poor survival in patients even when applying aggressive
treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment …

Background Pattern Recognition techniques can provide invaluable insights in the field of
neuro-oncology. This is because the clinical analysis of brain tumors requires the use of non …

High‐resolution magic angle spinning (HRMAS) MRS allows for direct measurements of non‐
liquid tissue and cell specimens to present valuable insights into the cellular metabolisms of …